WVE peer analysis
Wave Life Sciences (WVE) against its competitors: price, today's move, 1-year return and market value side by side.
WVE and its peers
| Company | Price | Today | 1-year return | Market cap |
|---|---|---|---|---|
| ALNY Alnylam | $161.37 | -2.20% | -64.10% | $22.10B |
| ARCT Arcturus | $11.03 | -9.22% | 14.54% | $313.51M |
| ARWR Arrowhead | $59.62 | -0.47% | 40.91% | $8.46B |
| BNTC Benitec Biopharma | $8.74 | -1.02% | -45.95% | $304.93M |
| IONS Ionis Pharmaceuticals | $41.82 | -3.91% | -43.62% | $7.23B |
| NTLA Intellia | $11.69 | -6.26% | -4.69% | $1.75B |
| PRQR ProQR Therapeutics | $1.39 | -3.47% | -48.90% | $196.16M |
| SLN Silence Therapeutics | $19.79 | 0.20% | 170.73% | – |
| SRPT Sarepta Therapeutics | $18.16 | -2.47% | -21.89% | $1.97B |
| STOK Stoke Therapeutics | $26.50 | 0.80% | -16.40% | $1.70B |
| WVE Wave Life Sciences | $3.59 | -1.10% | -56.75% | $708.05M |
- WVE's peers: ALNY (Alnylam), ARCT (Arcturus), ARWR (Arrowhead), BNTC (Benitec Biopharma), IONS (Ionis Pharmaceuticals), NTLA (Intellia), PRQR (ProQR Therapeutics), SLN (Silence Therapeutics).
Updated 2026-11-02 19:12 UTC